Century Therapeutics (NASDAQ:IPSC – Get Free Report) had its price target reduced by research analysts at HC Wainwright from $17.00 to $13.00 in a research report issued to clients and investors on Thursday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 364.29% […]
Piper Sandler Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $10 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) have earned an average rating of “Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have issued ratings on the stock in the last […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) has been assigned an average rating of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1 year target price among analysts […]
EF Hutton Acquisition Co. I restated their buy rating on shares of Century Therapeutics (NASDAQ:IPSC – Get Rating) in a research report report published on Monday morning, Benzinga reports. EF Hutton Acquisition Co. I currently has a $16.00 target price on the stock. IPSC has been the topic of several other reports. Chardan Capital restated […]